How Real Is the Health Care Spending Trend?
This article was originally published in RPM Report
Executive Summary
The US is in a four-year-long stretch of lower-than-expected health care spending growth. The sluggish economy is clearly a factor, but—the head of the US Medicare program argues—so are payment and delivery reforms at the federal level.
You may also be interested in...
Class Warfare: CMS Proposes Sweeping Changes to Part D; “Protected Class” Cuts Just the Start
The Centers for Medicare & Medicaid Services is celebrating the 10th anniversary of Part D by proposing the most sweeping changes to the Medicare drug benefit since it launched. Proposed revisions to the “Protected Classes” will get the most attention, but the rest of the rule may have more profound impacts going forward.
US FDA Alzheimer Guidance Update Reflects Changes In Biomarkers – And Leadership
Latest update to draft guidance on early Alzheimer’s drug development is the third iteration of a document first published in 2013. The history of the guidance is a reflection of structural and leadership changes in the neurology review team at FDA.
Biden’s Co-Pay Cap Is Silver Lining For Pharma In Drug Pricing Campaign
President Biden’s call to expand the US Medicare price negotiation program is naturally making headlines from his campaign-year State of the Union Address. But his call for a national cap on co-pays could be an important opportunity for industry in the years to come.